CD36 and atherosclerosis: Due to their ability to bind modified lipoproteins, specifically oxidized low-density lipoprotein (oxLDL), numerous scavenger receptors (CD36, LOX-1, MARCO, SR-B1, SR-PSOX, and SR-A1) have been shown to contribute to atherosclerosis progression (48, 49).